DerrickWeisonSuMD
Oncology • Fountain Valley, CAHematologic Oncology
Compassionate Cancer Care Medical Group
Dr. Su is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11180 Warner Ave.
Suite 351
Fountain Valley, CA 92708Phone+1 714-698-0300Fax+1 714-698-0303
Summary
- Dr. Derrick Su is an oncologist in Fountain Valley, CA and Laguna Hills, CA and is affiliated with multiple hospitals in the area, including Fountain Valley Regional Hospital and Medical Center and MemorialCare, Orange Coast Memorial Medical Center. He received his medical degree from Boston University School of Medicine and has been in practice 6 years. He specializes in hematologic oncology.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2014 - 2017
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2011 - 2014
Boston University School of MedicineClass of 2011
Boston UniversityMedical Sciences, 2004 - 2007
Certifications & Licensure
CA State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 24 citationsRuxolitinib Rechallenge Can Improve Constitutional Symptoms and Splenomegaly in Patients With Myelofibrosis: A Case Series.Aaron T. Gerds, Derrick W. Su, Anastasia Martynova, Benjamin Pannell, Sudipto Mukherjee
Clinical Lymphoma, Myeloma & Leukemia. 2018-11-01 - 8 citationsBiophysical technologies for understanding circulating tumor cell biology and metastasis.Derrick W. Su, Jorge Nieva
Translational Lung Cancer Research. 2017-08-01 - 4 citationsAsian-variant intravascular large B-cell lymphoma.Derrick W. Su, Whitney Pasch, Cristina Costales, Imran Siddiqi, Ann Mohrbacher
Proceedings. 2017-04-01
Journal Articles
- Larotrectinib in TRK fusion-positive, metastatic non-small cell lung cancer (NSCLC) after treatment with entrectinib in a patient with a history of coronary artery dis...Su D et al., Current Problems in Cancer: Case Reports, 6/2022
Other Languages
- Chinese (Mandarin), Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
